AstraZeneca Thailand appoints John Sery as new Country President
AstraZeneca (Thailand) Co., Ltd., a global leader in biopharmaceuticals, has officially announced the appointment of Mr. John Sery as the new Country President for Thailand to drive the organization's continued growth in the region.
This leadership change marks a significant milestone for AstraZeneca Thailand, with Mr. John Sery taking responsibility for strategic management, focusing on the development of health innovations and ensuring access to quality medicines for Thai patients.
With his extensive experience and expertise in the pharmaceutical industry, Mr. John Sery will lead the team in continuing the company's mission to build partnerships with both public and private sectors to elevate healthcare standards and improve the quality of life for the people of Thailand.
Furthermore, the company remains committed to continuously investing in and developing medical technologies to address the evolving public health needs of today, with a focus on building long-term sustainability for the country's healthcare system.
This appointment reflects the importance of the Thai market to AstraZeneca, which is prepared to continue building trust and promoting better health for Thai people through cutting-edge medical innovations.